Joinn Laboratories(China)Co.,Ltd. (603127.SS)
CNY 16.17
(-2.41%)
CNY 16.17
(-2.41%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 41.92 Million CNY | -30.32% |
| 2022 | 60.16 Million CNY | -12.96% |
| 2021 | 69.12 Million CNY | 223.4% |
| 2020 | 21.37 Million CNY | 132.97% |
| 2019 | 9.17 Million CNY | 917502613.67% |
| 2018 | 1.00 CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 118 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - CNY | 0.0% |
| 2024 Q1 | 35.53 Million CNY | 0.0% |
| 2024 Q2 | 28.95 Million CNY | 0.0% |
| 2023 Q4 | 41.92 Million CNY | -25.33% |
| 2023 Q1 | 59.5 Million CNY | -1.11% |
| 2023 FY | 41.92 Million CNY | -30.32% |
| 2023 Q3 | 56.14 Million CNY | 5.13% |
| 2023 Q2 | 53.41 Million CNY | -10.24% |
| 2022 Q4 | 60.16 Million CNY | -11.2% |
| 2022 FY | 60.16 Million CNY | -12.96% |
| 2022 Q3 | 67.75 Million CNY | 7.02% |
| 2022 Q2 | 63.31 Million CNY | -1.62% |
| 2022 Q1 | 64.35 Million CNY | -6.91% |
| 2021 Q3 | 49.8 Million CNY | -10.01% |
| 2021 Q1 | 59.5 Million CNY | 178.39% |
| 2021 FY | 69.12 Million CNY | 223.4% |
| 2021 Q2 | 55.34 Million CNY | -6.99% |
| 2021 Q4 | 69.12 Million CNY | 38.8% |
| 2020 FY | 21.37 Million CNY | 132.97% |
| 2020 Q3 | 23.96 Million CNY | -5.87% |
| 2020 Q4 | 21.37 Million CNY | -10.81% |
| 2020 Q2 | 25.45 Million CNY | 80.69% |
| 2020 Q1 | 14.09 Million CNY | 53.58% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 9.17 Million CNY | 917502613.67% |
| 2019 Q4 | 9.17 Million CNY | 61572563913932900.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 Q4 | 1.00 CNY | 0.0% |
| 2018 Q2 | - CNY | -100.0% |
| 2018 Q1 | 1.00 CNY | 0.0% |
| 2018 FY | 1.00 CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2012 FY | 118 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.1 Billion CNY | 96.198% |
| WuXi AppTec Co., Ltd. | 687.01 Million CNY | 93.898% |
| Autobio Diagnostics Co., Ltd. | 24.63 Million CNY | -70.178% |
| Thalys Medical Technology Group Inc. | 596.75 Million CNY | 92.975% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 267.61 Million CNY | 84.334% |
| Chemclin Diagnostics Co., Ltd. | 227.94 Million CNY | 81.608% |